PBK and lung cancer: In lung cancer, the upregulation of TOPK was reported to promote chemical‐resistance towards EGFR tyrosine kinase inhibitors,16 and facilitate hypoxia‐induced epithelial‐mesenchymal transition and the invasion of NSCLC cells.17